Invesco Ltd. Emergent Bio Solutions Inc. Transaction History
Invesco Ltd.
- $516 Billion
- Q4 2024
A detailed history of Invesco Ltd. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Invesco Ltd. holds 1,539,907 shares of EBS stock, worth $12.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,539,907
Previous 900,912
70.93%
Holding current value
$12.1 Million
Previous $7.52 Million
95.71%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding EBS
# of Institutions
172Shares Held
36.8MCall Options Held
336KPut Options Held
203K-
Black Rock Inc. New York, NY3.84MShares$30.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$25.1 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.14MShares$16.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.96MShares$15.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.48MShares$11.6 Million0.01% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $391M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...